Titan Medical Inc (TMDIF)

[QuidWilson]

It's not so much the price as the internal rate of return. Since any asset should yield a profit, it's the best use of capital that is of concern to firms. A lot of buyers could justify a $1b purchase if the yield is favorable. The opportunity cost of a high risk $25m purchase is great. They could use that same money for cash flow positive assets. Current state it's a guaranteed negative return with no guarantee that will turn around anytime soon. To encapsulate: in general firms care about rate of return, not necessarily price of asset.